In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $61.68, marking a -1.03% move from the previous day.

Viking Therapeutics VKTX has outperformed the market over the past 5 years by 41.66% on an annualized basis producing an ...

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

I'm bullish on Viking Therapeutics' weight-loss drug, but warn of risks and competition ahead. Click here to read my most ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $70.47 which represents a slight increase of $2.31 or 3.39% from the prior close of $68.16. The stock opened at $69.5 and ...

Below is a chart showing LUMN's trailing twelve month trading history, with the $3 strike highlighted in orange: And Viking Therapeutics Inc (Symbol: VKTX) saw options trading volume of 16,760 ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $66.73 which represents a slight increase of $3.92 or 6.24% from the prior close of $62.81. The stock opened at $63.08 and ...

Fintel reports that on September 11, 2024, JP Morgan initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a ...